BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

gmat paper

Expert replies
by CITI29 » Fri Jul 11, 2008 1:00 pm
A chemical company claims that, since only one of
520 rats that were given high doses of a new artificial
sweetener developed cancer while all the others
remained healthy, the sweetener is not carcinogenic
for human beings and ought to be approved for
human consumption.

Which of the following, if true, most strongly
supports the chemical company’s claim?
(A) Chemicals that are carcinogenic for rats are
usually also carcinogenic for other animals, such as
guinea pigs, used in experiments.
(B) The spontaneous incidence of cancer in this
particular strain of rat is approximately one in 540.
(C) Tests conducted on a certain strain of mouse
show that, of 500 mice given a dose of sweetener
similar to that given the rats, 53 developed cancer.
(D) Certain chemicals that are carcinogenic for
human beings have been shown not to be
carcinogenic for rats.
(E) The average lifespan of the strain of rat used in
the experiment is 2 years the chemical company
terminated the experiment when the rats were 13
months old.

ans is 'b'..kindly explain
Join the discussion
Source: — Critical Reasoning |

by newera » Sat Jul 12, 2008 6:12 pm
Oh this one is tough.

Conclusion: this company bases its "human consumption recommendations" on rat tests. So, its assumed that whatever happens to the rats technically happens to humans too.

A--other animals doesn't have to include humans
B--keyword here is SPONTANEOUS. 1/540 rats die for no reason. in relation to the stimulus, statistics support that that one rat had a freak death, totally unrelated to the sweetner. Thus, since the company bases its recommendations on the rats and technically, none of them died due to the sweetner, it is infact safe for humans to consume the sweetner.
C--irrelevant. we are talking about rats not mice.
D--this weakens not strenghtens.
E--irrelevant since the rats weren't around 2 yrs old anyway
Join the discussion

by nitya34 » Sat Mar 21, 2009 10:05 pm
Great Q indeed!!

is the option at B a typo?

one in 540?or one in 520?
Join the discussion

by S0laris » Sun Mar 22, 2009 6:09 am
freaky one bc there is no comparison with human except for assumption. In this case B - it supports sweetener's safity at least
we are the champions !
Join the discussion

by Brad.C » Sun May 15, 2016 6:45 am
B) The spontaneous incidence of cancer in this
particular strain of rat is approximately one in 540.
B looks good
Join the discussion

by graem83d » Sun May 15, 2016 7:37 am
i think option B looks good
Join the discussion